IRIS
BUONOMO, ANTONIO RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.476
EU - Europa 901
AS - Asia 213
AF - Africa 38
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.431
IT - Italia 438
NL - Olanda 177
CN - Cina 173
DE - Germania 115
IE - Irlanda 63
FI - Finlandia 49
CA - Canada 43
CI - Costa d'Avorio 32
CH - Svizzera 18
GB - Regno Unito 18
IN - India 14
FR - Francia 9
VN - Vietnam 7
EG - Egitto 6
SG - Singapore 6
TH - Thailandia 3
BE - Belgio 2
IR - Iran 2
MK - Macedonia 2
MX - Messico 2
RS - Serbia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
SI - Slovenia 1
TR - Turchia 1
Totale 2.632
Salva come PNG Salva come JPEG
Città #
Chandler 294
Ashburn 189
Amsterdam 167
Naples 120
Millbury 81
Des Moines 61
Napoli 61
Nanjing 53
Boston 47
Princeton 45
Ottawa 39
Lawrence 35
Beijing 34
Krefeld 32
Wilmington 23
Rome 20
Basel 17
Nanchang 15
Shenyang 15
Washington 15
Seattle 12
Hebei 11
Jiaxing 11
Milan 10
Caserta 8
Boise 7
Indiana 7
Kronberg 6
Lappeenranta 6
Pomigliano D'arco 6
Pune 6
Redwood City 6
Tianjin 6
Changsha 5
Guangzhou 5
Singapore 5
Bologna 4
Council Bluffs 4
Dong Ket 4
Norwalk 4
Pozzuoli 4
Qualiano 4
Brescia 3
Chicago 3
Dublin 3
Dung 3
Hanover 3
Jinan 3
Montalbano Jonico 3
Shenzhen 3
Boardman 2
Cairo 2
Caravaggio 2
Castellammare Di Stabia 2
Dearborn 2
Fairfield 2
Formia 2
Fremont 2
Gualtieri 2
Helsinki 2
Houston 2
Naaldwijk 2
Paris 2
Prato 2
Richmond 2
San Prisco 2
Sennori 2
Serra 2
Sesto San Giovanni 2
Skopje 2
Sorrento 2
Torre Annunziata 2
Vittorio Veneto 2
Acerra 1
Afragola 1
Alcamo 1
Astana 1
Aversa 1
Bari 1
Bayreuth 1
Brussels 1
Burlington 1
Caivano 1
Cambridge 1
Camparada 1
Casalnuovo Di Napoli 1
Casoria 1
Castellammare di Stabia 1
Cava De' Tirreni 1
Changchun 1
Chittagong 1
Città Di Castello 1
Cologno Monzese 1
Columbus 1
Downers Grove 1
Dubai 1
Duncan 1
Edinburgh 1
Ercolano 1
Fisciano 1
Totale 1.601
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 129
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 56
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 55
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 54
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 51
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 49
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 47
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 45
Asunaprevir for hepatitis C: A safety evaluation 45
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 43
Does compulsory vaccination limit personal freedom? Ethical issues 43
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 42
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 41
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 40
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 38
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 38
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 37
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 37
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 36
Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome 36
Beclabuvir for the treatment of hepatitis C 35
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 35
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 35
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 34
Current evidence on the management of hepatitis B in pregnancy 33
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 33
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 33
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 33
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 33
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 32
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 32
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 31
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 31
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 31
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 31
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 31
A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial 31
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 30
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 30
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 30
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 29
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 29
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 28
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 27
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 27
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 27
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 27
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 27
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 25
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 25
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 24
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 24
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 23
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 22
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 22
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus 22
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 21
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 21
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 20
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 20
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 20
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 20
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 20
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 20
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 19
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. 19
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 19
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 19
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 18
Trends in Caesarean Section Rate According to Robson Group Classification among Pregnant Women with SARS-CoV-2 Infection: A Single-Center Large Cohort Study in Italy 18
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 18
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 18
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 17
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. 17
Influence of ITPase activity on decreases of hemoglobin during treatment with Interferon-free DAA-based and ribavirin in HCV-related cirrhosis 17
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 17
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 16
Diabetes and COVID-19: The potential role of mTOR 16
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 16
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 16
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 16
In vivo antiviral activity of telbivudine against HIV-1: a case report. 16
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 16
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 16
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 16
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 15
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 15
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 15
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 14
Efficacy and Safety of Sofosbuvir in Treatment of Chronic Hepatitis C: The Dawn of the a New Era. 14
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 13
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 13
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 13
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 13
A retrospective study on HIV and syphilis. 13
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 12
Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient 12
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 12
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 12
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection. 11
Totale 2.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 2 4 30
2019/2020227 99 8 6 9 16 10 5 9 2 11 35 17
2020/2021139 23 3 7 5 10 19 8 4 18 19 11 12
2021/2022479 2 4 0 4 3 21 3 19 64 44 116 199
2022/2023995 85 60 23 50 99 108 27 181 129 180 38 15
2023/2024611 27 112 131 65 63 117 8 65 18 5 0 0
Totale 2.834